Pharmafile Logo
Pharmafocus logo
Advanced Search

Galderma

Showing 7 posts of 7 posts found.

Galderma launches clinical trials for nemolizumab in systemic sclerosis and chronic pruritus of unknown origin

June 27, 2025
Research and Development Dermatology, Galderma, chronic pruritus of unknown origin, clinical trials, dermatological conditions, dermatology, nemolizumab, systemic sclerosis

Galderma has announced the launch of two phase 2 clinical trials evaluating its monoclonal antibody, nemolizumab, in two conditions: systemic …

News
Galderma image

Merck and Galderma breach ABPI code

December 8, 2014
Medical Communications, Sales and Marketing ABPI, Erbitux, Galderma, PMCPA, merch

Merck Serono and Galderma will be named in advertisements as guilty of the most serious breach of the ABPI Code …

News
Galderma image

Galderma earns wrath of PMCPA in unprecedented case

October 7, 2014
Medical Communications, Research and Development, Sales and Marketing ABPI, Azzalure, Galderma, PMCPA, Pliaglis, UK, code of practise

Galderma has sensationally pulled out of the UK’s good conduct pact after the watchdog overseeing the ABPI Code found ‘extremely …

News
Allergan image

Allergan reprimanded over Botox promotion

March 19, 2014
Medical Communications, Sales and Marketing ABPI, Allergan, Botox, Galderma, PMCPA, vistabel

Allergan has been found guilty of breaching six clauses of the ABPI’s Code of Practice over its market research for …

News
AstraZeneca

AZ partners with Galderma on psoriasis research

March 9, 2011
Research and Development AZ, AstraZeneca, Galderma, dermatology, psoriasis

AstraZeneca has signed a five-year deal with dermatology specialist Galderma Pharma to develop new treatments for conditions including psoriasis. It …

News

Woolley Pau wins Galderma UK account

May 21, 2010
Medical Communications Galderma, Woolley Pau

Dermatology specialist Galderma UK has appointed advertising agency Woolley Pau to work on a number of product launches. The agency …

News

Québec supports $38m Galderma investment

February 18, 2010
Manufacturing and Production Canada, Galderma, Quebec, biopharmaceutical

The regional government in Québec in Canada is to contribute 10% of the costs of a new investment in manufacturing …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025